• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物疗法与甲银屑病

Biological therapy and nail psoriasis.

作者信息

Lawry Monica

机构信息

Nail Disease Clinic, UC Davis, Department of Dermatology, Sacramento, California 95825, USA.

出版信息

Dermatol Ther. 2007 Jan-Feb;20(1):60-7. doi: 10.1111/j.1529-8019.2007.00112.x.

DOI:10.1111/j.1529-8019.2007.00112.x
PMID:17403261
Abstract

Nail psoriasis affects 50% of psoriasis patients and in many cases causes impairment of manual dexterity, pain, and psychologic stress. Despite the fact that about 80% of psoriatic arthritis patients have nail involvement, patients rarely receive treatment for nail disease. Because of great difficulty in drug delivery to site of action and significant toxicities of most conventional systemic therapies, treatment of nail psoriasis can be very challenging. Biological therapy for psoriasis and psoriatic arthritis is now widely used, and early evidence indicates it may have significant benefit for some patients with psoriatic nail disease. This article reviews the clinical manifestations of nail psoriasis and discusses how to use specific biologic therapies that may provide significant new treatment options for this challenging disease.

摘要

甲银屑病影响50%的银屑病患者,在许多情况下会导致手部灵活性受损、疼痛和心理压力。尽管约80%的银屑病关节炎患者有甲受累情况,但患者很少接受甲病治疗。由于药物输送到作用部位存在很大困难,且大多数传统全身疗法有显著毒性,甲银屑病的治疗极具挑战性。银屑病和银屑病关节炎的生物疗法目前已广泛应用,早期证据表明其可能对一些银屑病甲病患者有显著益处。本文综述了甲银屑病的临床表现,并讨论了如何使用特定生物疗法,这些疗法可能为这种具有挑战性的疾病提供重要的新治疗选择。

相似文献

1
Biological therapy and nail psoriasis.生物疗法与甲银屑病
Dermatol Ther. 2007 Jan-Feb;20(1):60-7. doi: 10.1111/j.1529-8019.2007.00112.x.
2
Nail psoriasis and biologics.甲银屑病与生物制剂
J Cutan Med Surg. 2009 Jan-Feb;13(1):1-5. doi: 10.2310/7750.2008.08012.
3
TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis.肿瘤坏死因子-α拮抗剂与甲银屑病:一项针对成年银屑病患者的开放性、为期24周的前瞻性队列研究。
Expert Opin Biol Ther. 2013 Apr;13(4):469-73. doi: 10.1517/14712598.2013.736960. Epub 2012 Nov 16.
4
A review of biologic treatments for psoriasis with emphasis on infliximab.以英夫利昔单抗为重点的银屑病生物治疗综述。
Skin Therapy Lett. 2007 Apr;12(3):1-4.
5
Marked improvement in nail psoriasis during treatment with etanercept.治疗用依那西普治疗时,指甲银屑病有明显改善。
Dermatol Ther. 2011 Sep-Oct;24(5):498-500. doi: 10.1111/j.1529-8019.2012.01472.x.
6
Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.生物治疗下患有甲银屑病的患者的甲真菌病:比较依那西普、英夫利昔单抗和阿达木单抗的随机、前瞻性开放标签研究。
Expert Opin Biol Ther. 2013 May;13(5):625-9. doi: 10.1517/14712598.2013.783561. Epub 2013 Mar 26.
7
Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept.银屑病的生物治疗:肿瘤坏死因子抑制剂英夫利昔单抗、依那西普和阿达木单抗,以及靶向T细胞疗法依法利珠单抗和阿法赛特的最新进展。
J Drugs Dermatol. 2005 Sep-Oct;4(5):544-55.
8
[Biologic therapy: a new and promising option to treat psoriasis].
Rev Med Inst Mex Seguro Soc. 2008 Jul-Aug;46(4):405-14.
9
[Biological treatment of psoriasis and psoriatic arthritis].[银屑病和银屑病关节炎的生物治疗]
Ugeskr Laeger. 2008 Jun 9;170(24):2148-50.
10
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.将生物制剂纳入中度至重度斑块状银屑病管理的建议:个体化患者治疗方法
J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1.

引用本文的文献

1
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.比美吉珠单抗治疗甲银屑病的快速临床反应:一项回顾性多中心36周真实世界研究
Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378.
2
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case-Control 24-Month Longitudinal Study.口服益生菌唾液链球菌 K-12 改善银屑病:一项为期 24 个月的病例对照纵向研究。
Probiotics Antimicrob Proteins. 2022 Jun;14(3):573-578. doi: 10.1007/s12602-022-09937-1. Epub 2022 Apr 13.
3
A Comparison of The Effects of Clobetasol 0.05% and Photodynamic Therapy Using Aminolevulinic Acid With Red Light in the Treatment of Severe Nail Psoriasis.
0.05%氯倍他索与使用氨基乙酰丙酸联合红光的光动力疗法治疗重度甲银屑病的疗效比较
J Lasers Med Sci. 2020 Winter;11(1):3-7. doi: 10.15171/jlms.2020.02. Epub 2020 Jan 18.
4
[The skin and rheumatism].[皮肤与风湿病]
Orthopade. 2019 Nov;48(11):905-910. doi: 10.1007/s00132-019-03811-9.
5
Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.阿达木单抗治疗甲银屑病:来自一项 3 期、随机、安慰剂对照试验的 52 周疗效和安全性。
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2168-2178. doi: 10.1111/jdv.15793. Epub 2019 Sep 4.
6
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.甲银屑病发病机制的新见解及治疗策略概述
Drug Des Devel Ther. 2017 Aug 30;11:2527-2535. doi: 10.2147/DDDT.S136986. eCollection 2017.
7
Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitário Evangélico de Curitiba.库里蒂巴福音大学医院皮肤科中心甲银屑病的发病率、临床表现及手术夹闭治疗
An Bras Dermatol. 2016 May-Jun;91(3):300-5. doi: 10.1590/abd1806-4841.20164296.
8
Nail psoriasis: the journey so far.甲银屑病:迄今为止的历程。
Indian J Dermatol. 2014 Jul;59(4):319-33. doi: 10.4103/0019-5154.135470.
9
Randomized controlled trial of a water-soluble nail lacquer based on hydroxypropyl-chitosan (HPCH), in the management of nail psoriasis.羟丙基壳聚糖(HPCH)水基指甲油治疗甲银屑病的随机对照试验。
Clin Cosmet Investig Dermatol. 2014 May 27;7:185-90. doi: 10.2147/CCID.S61659. eCollection 2014.
10
Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.挑战性区域银屑病与优特克单抗生物疗法:疾病模式的影响
J Biomed Biotechnol. 2012;2012:413767. doi: 10.1155/2012/413767. Epub 2012 Aug 13.